Literature DB >> 11591178

Quiescence, cell viability, apoptosis and necrosis of smooth muscle cells using different growth inhibitors.

J Pelisek1, S Armeanu, S Nikol.   

Abstract

Smooth muscle cells and endothelial cells play an important role in cardiovascular diseases and may therefore be a potential target for gene therapy. Most in vitro experiments are performed using proliferating cell cultures. Nevertheless, non-dividing cells would represent more realistic in vivo conditions for gene therapy. Therefore, a simple method to achieve physiologically quiescence in cell cultures is needed for experiments. Growth to confluence is sufficient for endothelial cells to reach quiescence, in contrast to smooth muscle cells. Alternative techniques were investigated to achieve quiescence for smooth muscle cells. N-acetyl-cysteine, heparin, aphidicolin and serum-free medium are known inhibitors of smooth muscle cell proliferation and were tested for cell viability, necrosis and apoptosis. The inhibition status was evaluated counting cells in a cell counter. Toxicity, necrosis and apoptosis were determined using FACS analysis. Then, smooth muscle cells and endothelial cells were transfected with plasmid containing the beta-galactosidase gene using liposomes. Analysis of gene expression in transfected cells included a quantitative beta-galactosidase assay and X-gal staining. Growth inhibition was achieved with all agents tested. Using N-acetyl-cysteine, only slightly reduced growth rates were observed. Aphidicolin stopped cell growth almost immediately, but demonstrated enhanced toxicity. The amount of apoptotic and necrotic cells was lowest using heparin in the presence of foetal calf serum. Transfection experiments using stationary cultures of smooth muscle cells using heparin or aphidicolin demonstrated 5-10-fold lower transfection rates compared to transfected proliferating cell cultures serving as controls. Transfection experiments using stationary cultures of endothelial cells using growth inhibition through confluence demonstrated 40-fold lower transfection rates than transfected proliferating cell cultures. Transfer efficiency was much lower in endothelial cells compared to smooth muscle cells. In conclusion, quiescent cells simulate more realistically the in vivo situation and may therefore represent a better model for future in vivo experiments based on in vitro findings.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11591178      PMCID: PMC6496739          DOI: 10.1046/j.0960-7722.2001.00215.x

Source DB:  PubMed          Journal:  Cell Prolif        ISSN: 0960-7722            Impact factor:   6.831


  36 in total

1.  Suppression of neointimal thickening by a newly developed HMG-CoA reductase inhibitor, BAYw6228, and its inhibitory effect on vascular smooth muscle cell growth.

Authors:  M Igarashi; Y Takeda; S Mori; N Ishibashi; E Komatsu; K Takahashi; T Fuse; M Yamamura; K Kubo; Y Sugiyama; Y Saito
Journal:  Br J Pharmacol       Date:  1997-03       Impact factor: 8.739

Review 2.  Induction of apoptosis in cells of the immune system by cytotoxic stimuli.

Authors:  T G Cotter
Journal:  Semin Immunol       Date:  1992-12       Impact factor: 11.130

3.  Gene transfer into the carotid artery using an adventitial collar: comparison of the effectiveness of the plasmid-liposome complexes, retroviruses, pseudotyped retroviruses, and adenoviruses.

Authors:  M Laitinen; T Pakkanen; E Donetti; R Baetta; J Luoma; P Lehtolainen; H Viita; R Agrawal; A Miyanohara; T Friedmann; W Risau; J F Martin; M Soma; S Ylä-Herttuala
Journal:  Hum Gene Ther       Date:  1997-09-20       Impact factor: 5.695

4.  Efficiency of plasmid delivery and expression after lipid-mediated gene transfer to human cells in vitro.

Authors:  Z Bebök; A M Abai; J Y Dong; S A King; K L Kirk; G Berta; B W Hughes; A S Kraft; S W Burgess; W Shaw; P L Felgner; E J Sorscher
Journal:  J Pharmacol Exp Ther       Date:  1996-12       Impact factor: 4.030

Review 5.  Molecular biology and post-angioplasty restenosis.

Authors:  S Nikol; T Y Huehns; B Höfling
Journal:  Atherosclerosis       Date:  1996-06       Impact factor: 5.162

6.  Expression of genes for platelet-derived growth factor in adult human venous endothelium. A possible non-platelet-dependent cause of intimal hyperplasia in vein grafts and perianastomotic areas of vascular prostheses.

Authors:  A Limanni; T Fleming; R Molina; H Hufnagel; R E Cunningham; D F Cruess; J B Sharefkin
Journal:  J Vasc Surg       Date:  1988-01       Impact factor: 4.268

7.  Fast and reproducible vascular neointima formation in the hamster carotid artery: effects of trapidil and captopril.

Authors:  H Matsuno; J M Stassen; M F Hoylaerts; J Vermylen; H Deckmyn
Journal:  Thromb Haemost       Date:  1995-12       Impact factor: 5.249

8.  Prevention of Restenosis Using the Gene for Cecropin Complexed with DOCSPER Liposomes under Optimized Conditions.

Authors: 
Journal:  Int J Angiol       Date:  2000-03

Review 9.  Control of cell division by aphidicolin without adverse effects upon resting cells.

Authors:  S Spadari; F Focher; F Sala; G Ciarrocchi; G Koch; A Falaschi; G Pedrali-Noy
Journal:  Arzneimittelforschung       Date:  1985

10.  Sodium butyrate inhibits platelet-derived growth factor-induced proliferation of vascular smooth muscle cells.

Authors:  K Ranganna; T Joshi; F M Yatsu
Journal:  Arterioscler Thromb Vasc Biol       Date:  1995-12       Impact factor: 8.311

View more
  6 in total

1.  Stabilized nonviral formulations for the delivery of MCP-1 gene into cells of the vasculoendothelial system.

Authors:  Martin C Lenter; Patrick Garidel; Jaroslav Pelisek; Ernst Wagner; Manfred Ogris
Journal:  Pharm Res       Date:  2004-04       Impact factor: 4.200

2.  Heparin inhibits the motility and proliferation of human myometrial and leiomyoma smooth muscle cells.

Authors:  Holly R Mason; Romana A Nowak; Cynthia C Morton; John J Castellot
Journal:  Am J Pathol       Date:  2003-06       Impact factor: 4.307

3.  Growth inhibition of bovine pulmonary artery smooth muscle cells following long-term heparin treatment.

Authors:  Hicham Mrabat; Hari G Garg; Charles A Hales
Journal:  J Cell Physiol       Date:  2009-12       Impact factor: 6.384

4.  Live in vivo imaging of Egr-1 promoter activity during neonatal development, liver regeneration and wound healing.

Authors:  Philipp Dussmann; Judith I Pagel; Sabina Vogel; Terese Magnusson; Rene Zimmermann; Ernst Wagner; Wolfgang Schaper; Manfred Ogris; Elisabeth Deindl
Journal:  BMC Dev Biol       Date:  2011-05-20       Impact factor: 1.978

5.  A model of guided cell self-organization for rapid and spontaneous formation of functional vessels.

Authors:  L Andrique; G Recher; K Alessandri; N Pujol; M Feyeux; P Bon; L Cognet; P Nassoy; A Bikfalvi
Journal:  Sci Adv       Date:  2019-06-12       Impact factor: 14.136

6.  Serum can overcome contact inhibition in confluent human pulmonary artery smooth muscle cells.

Authors:  Victor Solodushko; Heba A Khader; Brian W Fouty
Journal:  PLoS One       Date:  2013-08-06       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.